A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 18,415 shares of LMAT stock, worth $1.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,415
Holding current value
$1.9 Million
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$80.3 - $92.89 $1.48 Million - $1.71 Million
18,415 New
18,415 $1.71 Million
Q1 2024

May 15, 2024

BUY
$54.0 - $71.06 $381,726 - $502,323
7,069 New
7,069 $469,000
Q3 2023

Nov 15, 2023

BUY
$53.45 - $67.01 $118,177 - $148,159
2,211 Added 41.23%
7,574 $412,000
Q2 2023

Aug 14, 2023

SELL
$50.38 - $68.21 $57,937 - $78,441
-1,150 Reduced 17.66%
5,363 $360,000
Q1 2023

May 15, 2023

BUY
$44.73 - $51.68 $63,248 - $73,075
1,414 Added 27.73%
6,513 $335,000
Q4 2022

Feb 14, 2023

SELL
$41.94 - $52.25 $505,628 - $629,926
-12,056 Reduced 70.28%
5,099 $235,000
Q3 2022

Nov 14, 2022

BUY
$45.29 - $55.99 $166,803 - $206,211
3,683 Added 27.34%
17,155 $869,000
Q2 2022

Aug 15, 2022

BUY
$39.05 - $47.85 $526,081 - $644,635
13,472 New
13,472 $614,000
Q3 2021

Nov 15, 2021

SELL
$53.09 - $60.57 $535,571 - $611,030
-10,088 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$47.74 - $63.33 $143,363 - $190,179
-3,003 Reduced 22.94%
10,088 $616,000
Q1 2021

May 17, 2021

SELL
$40.19 - $51.5 $213,449 - $273,516
-5,311 Reduced 28.86%
13,091 $639,000
Q4 2020

Feb 16, 2021

BUY
$31.44 - $41.27 $578,558 - $759,450
18,402 New
18,402 $745,000
Q3 2019

Nov 14, 2019

SELL
$27.91 - $35.78 $336,343 - $431,184
-12,051 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$25.55 - $30.79 $307,903 - $371,050
12,051 New
12,051 $337,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.27B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.